Atlas Trials

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Clinical trial NCT02960646 · COMPLETED

Trial details

NCT number
NCT02960646
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAplastic AnemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelomonocytic LeukemiaChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLymphoblastic LymphomaMyelodysplastic SyndromeMyeloproliferative NeoplasmPlasma Cell MyelomaRecurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Start date
2017-01-18
Primary completion
2023-02-13
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.